Your browser doesn't support javascript.
loading
Slaying the "Troll of Transplantation"-new frontiers in cytomegalovirus management: A report from the CMV International Symposium 2023.
Kotton, Camille N; Torre-Cisneros, Julian; Yakoub-Agha, Ibrahim.
  • Kotton CN; Transplant and Immunocompromised Host Infectious Diseases, Infectious Diseases Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Torre-Cisneros J; Maimónides Institute for Biomedical Research of Cordoba (IMIBIC)/Reina Sofía University Hospital/University of Cordoba (UCO), Cordoba, Spain.
  • Yakoub-Agha I; CIBERINFEC, ISCIII - CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
Transpl Infect Dis ; 26(1): e14183, 2024 Feb.
Article en En | MEDLINE | ID: mdl-37942955
ABSTRACT
The 2023 International CMV Symposium took place in Barcelona in May 2023. During the 2-day meeting, delegates and faculty discussed the ongoing challenge of managing the risk of cytomegalovirus infection (the Troll of Transplantation) after solid organ or hematopoietic cell transplantation. Opportunities to improve outcomes of transplant recipients by applying advances in antiviral prophylaxis or pre-emptive therapy, immunotherapy, and monitoring of cell-mediated immunity to routine clinical practice were debated and relevant educational clinical cases presented. This review summarizes the presentations, cases, and discussions from the meeting and describes how further advances are needed before the Troll of Transplantation is slain.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Órganos / Infecciones por Citomegalovirus / Trasplante de Células Madre Hematopoyéticas Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Órganos / Infecciones por Citomegalovirus / Trasplante de Células Madre Hematopoyéticas Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article